Study for treatment of resected stage III colon cancer
Primary disease category: Cancer
Secondary disease categories: Colorectal Cancer
Sponsor: Southwest Oncology Group
Protocol number: C80702
Projected enrollment dates: January 2014 to February 2017
Official study title: A Phase III Trial of 6 Versus 12 Treatments of Adjuvant Folfox plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
External link(s):
UA Cancer Center Website
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/NCT01150045